With Academic Collaborators, GSK To Plug For ‘Electroceuticals’
This article was originally published in Start Up
GlaxoSmithKline will fund nonprofit labs across several biomedical and engineering disciplines and offer a $1 million cash prize to probe the role of neural activity in disease. The goal is to build new devices that treat a range of diseases “in their own electrical language.”
You may also be interested in...
Electroceuticals could replace the use of pharmaceuticals in many chronic diseases, offering effective treatments without, perhaps, side effects. Medtechs pioneering these next-gen neuromodulation devices are sparking investor interest.
Major Chinese biopharma contract services group WuXi Biologics' share price plummeted after it said external factors would contribute to it missing original revenue targets this year in multiple areas.